The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
MRI has emerged as one of several urgently needed candidate disease progression biomarkers for the neurodegenerative disorder amyotrophic lateral sclerosis (ALS), not least due to its unique ability to non-invasively assess structural and functional cerebral pathology. We sought to identify the exte...
Hoofdauteurs: | Menke, R, Proudfoot, M, Talbot, K, Turner, M |
---|---|
Formaat: | Journal article |
Gepubliceerd in: |
Elsevier
2017
|
Gelijkaardige items
-
The two-year progression of structural and functional cerebral MRI in amyotrophic lateral sclerosis
door: R.A.L. Menke, et al.
Gepubliceerd in: (2018-01-01) -
Imaging cerebral activity in amyotrophic lateral sclerosis
door: Proudfoot, M, et al.
Gepubliceerd in: (2019) -
Motor system biomarkers in amyotrophic lateral sclerosis
door: Edmond, EC, et al.
Gepubliceerd in: (2019) -
Widespread grey matter pathology dominates the longitudinal cerebral MRI and clinical landscape of amyotrophic lateral sclerosis.
door: Menke, R, et al.
Gepubliceerd in: (2014) -
Imaging Cerebral Activity in Amyotrophic Lateral Sclerosis
door: Malcolm Proudfoot, et al.
Gepubliceerd in: (2019-01-01)